Effect of Barberry on the symptoms of withdrawal syndrome

Phase 3

Recruiting

• Conditions: Addiction syndrome.; Mental and behavioural disorders due to psychoactive substance use; f10-f11-f1

• Registration Number: IRCT20170404033202N5
• Lead Sponsor: Sabzevar University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Acquiring informed consent; Having full vigilance when completing the consent form; Accompanying a trusted person in the family

Exclusion Criteria

Existence of illness; The use of another drug by the patient

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Rhinorrhea. Timepoint: Every week up to 2 months. Method of measurement: Checklist.;Diarrhea. Timepoint: Every week up to 2 months. Method of measurement: Checklist.;Reduce appetite. Timepoint: Every week up to 2 months. Method of measurement: Checklist.;Dyspnea. Timepoint: Every week up to 2 months. Method of measurement: Visual Scale of Pain.;Obsession. Timepoint: Every week up to 2 months. Method of measurement: Test Beck.

Secondary Outcome Measures

Name	Time	Method
Occupation. Timepoint: first. Method of measurement: chek List.;Age. Timepoint: first. Method of measurement: Birth certificate.;Sex. Timepoint: first. Method of measurement: male - female.